peptide mammalian sterile 20-like kinase 1 inhibitors (Vasade)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepeptide mammalian sterile 20-like kinase 1 inhibitors (Vasade)
Drug Alias NameMIP-120 (Vasade)peptide Mst-1 inhibitors (Vasade)TAT-120
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSerine/threonine-protein kinase 4 inhibitors
TargetsSerine/threonine-protein kinase 4
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVasade Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVasade Biosciences Inc
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A